Uncovering the Regulators of Cellular Plasticity by Direct Reprogramming
Cellular reprogramming has revolutionized stem cell biology by allowing the generation of stem cells, progenitors, or somatic cell identities with small combinations of transcription factors (TFs). Currently, the limited understan...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
PID2019-109354GB-I00
EL PAPEL DEL C/EBPA EN LA REMODELACION DEL GENOMA DURANTE LA...
472K€
Cerrado
PGC2018-098626-B-I00
ANALISIS DEL PAPEL DE LAS ENZIMAS MODIFICANTES DEL RNA EN LA...
106K€
Cerrado
dynamicmodifications
Complexity and dynamics of nucleic acids modifications in vi...
2M€
Cerrado
PID2021-123144OB-I00
CONTROL DE LA HOMEOSTASIS DEL PROTEOMA EN PLURIPOTENCIA
182K€
Cerrado
PID2019-105739GB-I00
IMPACTO DEL METABOLISMO Y ENVEJECIMIENTO EN PLURIPOTENCIA A...
194K€
Cerrado
Información proyecto RePLASTIC
Duración del proyecto: 25 meses
Fecha Inicio: 2022-06-15
Fecha Fin: 2024-07-31
Líder del proyecto
LUNDS UNIVERSITET
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
223K€
Descripción del proyecto
Cellular reprogramming has revolutionized stem cell biology by allowing the generation of stem cells, progenitors, or somatic cell identities with small combinations of transcription factors (TFs). Currently, the limited understanding of how these different degrees of plasticity are established and maintained keeps on hold the application of reprogrammed cells in the clinic. With the RePLASTIC project, I propose to uncover novel regulators that define degrees of plasticity and control cell identity, with an interdisciplinary approach merging the fields of gene editing, stem cells and immunology. I will develop an innovative platform to evaluate the impact of gene knockout across the process of cell reprogramming in human cells, comparing multiple cell conversion scenarios: pluripotency, multipotency (hematopoietic stem cells) and unipotency (dendritic cells). For this, I will carry out a CRISPR/Cas9 knockout screening coupled with next-generation sequencing using custom-designed sgRNA libraries targeting TFs, chromatin regulators, and RNA modifiers. After sequencing, I will determine the molecular targets that are relevant by comparing the three reprogramming systems. Genes involved in cell conversion will be defined as regulators of plasticity, and top hits will be validated to study their molecular mechanism and role. Certainly, RePLASTIC will open new research avenues on the basic principles of cellular plasticity and provide ground-breaking technologies that may contribute to immunotherapy, regeneration and cancer. I will pursue this project as an incoming researcher supervised by Dr. Filipe Pereira (Lund University, Sweden). During my stay, I will acquire hands-on expertise in cutting-edge techniques: direct reprogramming, hematopoietic/immune cells, gene editing, deep sequencing. I will also gain experience in mentorship and writing skills and expand my network by attending national and international meetings to present my work and foster new collaborations.